GNMXvsPBEETF Comparison
VS
Corgi Genomics & Precision Medicine ETF (GNMX) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Healthcare. GNMX is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.58% for PBE. Run a side-by-side ETF comparison of GNMX and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNMX vs PBE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNMX PBE | +1.85%+2.57% | n/a+13.26% | n/a+10.25% | n/a+37.00% | n/a+44.35% | n/a+23.92% |
| Flows | GNMX PBE | -+$5M | -+$4M | -+$2M | --$17M | --$51M | --$45M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNMX PBE | n/a+18.74% | n/a+18.86% | n/a+20.25% | n/a+22.48% |
| Max drawdown | GNMX PBE | n/a-4.30% | n/a-11.70% | n/a-22.21% | n/a-34.74% |
| Max drawdown duration | GNMX PBE | n/a17d | n/a166d | n/a324d | n/a1540d |
Trading data
GNMX | PBE | |
Last sale 7/27/2026 at 1:30 PM | $89.85 | |
| Previous close 07/24/2026 | $89.59 | |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexGNMX | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
GNMX | PBE | |
|---|---|---|
| Last price | – | $89.85 |
| 1D performance | – | +0.29% |
| AuM | $1.64 M | $282.11 M |
| E/R | 0.35% | 0.58% |
Characteristics
GNMX | PBE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Corgi Funds | Invesco |
| Benchmark | - | Dynamic Biotech & Genome Intellidex Index |
| N° of holdings | 57 | 30 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 6, 2026 | June 23, 2005 |
| ESG | No | No |
Advertisement
Exposure
Countries
GNMX
USA
89.37%
Other
10.63%
PBE
USA
97.25%
Other
2.75%
Sectors
GNMX
Healthcare
98.21%
Other
1.79%
PBE
Healthcare
100%
Other
-0%
Advertisement
Diversification
GNMX
Total weight of top 15 holdings out of 15
53.1%
PBE
Total weight of top 15 holdings out of 15
60.29%
Top 15 holdings
Data as of June 30, 2026
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
PBE
Vertex Pharmaceuticals, Inc.
5.12%
Biogen, Inc.
5.08%
Amgen, Inc.
4.84%
Royalty Pharma Plc
4.74%
Regeneron Pharmaceuticals, Inc.
4.53%
Alnylam Pharmaceuticals, Inc.
4.48%
Gilead Sciences, Inc.
4.34%
United Therapeutics Corp.
4.26%
Bio-Techne Corp.
3.67%
Veracyte, Inc.
3.39%
CareDx, Inc.
3.31%
Vericel Corp.
3.27%
Repligen Corp.
3.16%
PTC Therapeutics, Inc.
3.09%
Protagonist Therapeutics, Inc.
3.02%
Frequently asked questions about GNMX and PBE
Which ETF is bigger: GNMX or PBE?
As of July 24, 2026, GNMX holds $1.64 M in assets under management (AUM), while PBE manages $282.11 M.
What sectors do the GNMX and PBE ETFs invest in?
GNMX leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.
What are the top holdings of the GNMX ETF and PBE ETF?
GNMX top holdings include Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc.. PBE holds in its top three: Vertex Pharmaceuticals, Inc., Biogen, Inc. and Amgen, Inc..
Which ETF is more diversified: GNMX or PBE?
GNMX holds 57 securities with 53.1% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 60.29%.
Advertisement
Advertisement
